The Children's Vaccine Initiative established a Product Development Gr
oup in 1991 to help in the development of oral poliovaccines of improv
ed thermostability. Under the auspices oi this group, the effect of di
fferent stabilizers on the loss oi infectivity of commercial monovalen
t type 3 live poliovaccine bulks at 37 degrees C, 42 degrees C and 45
degrees C has been examined. The only effective conditions were the ma
intenance of the pH at 6.5, and the use of deuterium oxide at a concen
tration of 90%. Ail other additives, including detergents, albumin, an
tiviral compounds, sucrose and magnesium chloride, alone or in combina
tion either had no effect or increased the rate oi loss of infectivity
. (C) 1998 The International Association of Biological Standardization
.